ISRCTN06722585已完成不适用
PRION-1: Quinacrine for human prion disease. A partially randomised patient preference trial to evaluate the activity and safety of quinacrine in human prion disease
Medical Research Council (UK)0 个研究点目标入组 160 人开始时间: 2004年3月24日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Eligible patients will be adults or children aged 12 years or more diagnosed with any type of human prion disease, and without clinical or laboratory abnormalities contraindicating use of quinacrine.
排除标准
- •1. In a coma, or in a pre-terminalphase of disease such that prolongation of the current quality of life would not be supported
- •2. Have known hypersensitivity to quinacrine
- •3. Have been taking any other putative anti-prion therapy for less than 8 weeks
研究者
相似试验
已完成
不适用
PRION-1: Quinacrine for Human Prion DiseasePrion DiseaseNCT00104663Medical Research Council160
已完成
2 期
CJD (Creutzfeldt-Jakob Disease) Quinacrine StudyCreutzfeldt-Jakob DiseaseNCT00183092University of California, San Francisco69
已完成
不适用
Effectiveness of pyrroloquinone quinone amino acid on mental status of Japanese subjectsHealthy adultJPRN-UMIN000032270Kagawa Nutrition University50
进行中（未招募）
1 期
Phase II Randomized Clinical Trial of quinacrine versus metronidazole in resistant giardiasis in children: Quin4KidsIntestinal giardiasisCTIS2023-510227-30-00Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz48
尚未招募
4 期
Effect of Primaquine in the patients of P.vivax and P.falciparum malaria.CTRI/2010/091/001040il50